• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素(安特尔)激素疗法对患有勃起功能障碍、老年男性部分雄激素缺乏症和心血管疾病男性的疗效与安全性

[Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].

作者信息

Kalinchenko S Iu, Vorslov L O, Aglamazian N L, Morgunov L Iu

出版信息

Urologiia. 2007 Jan-Feb(1):57, 59-61.

PMID:17472002
Abstract

Partial androgen deficiency of aging male (PADAM) manifests with sexual dysfunction and is associated with many diseases, primarily, cardiovascular. After the age of 30-40 a testosterone level falls 1-2% a year. The number of men with testosterone deficiency grows from 8% in 40-60-year-olds to 85% at the age over 80 years. Low testosterone correlates with such risk factors of cardiovascular diseases as dyslipidemia, atherosclerosis, low fibrinolysis, insulin resistance and abdominal obesity. Correction of androgenic deficiency can be conducted with the drug androgel which represents a new system of transdermal testosterone delivery. In contrast to vasoactive drugs, androgel affects pathogenetic mechanisms of erectile dysfunction and thus attenuates factors of cardiovascular risk. Androgel is used externally and is more effective than intramuscular and oral analogues. Also, the drug improves lipid spectrum. By activating lipolysis, testosterone reduces the amount of visceral fat thus lowering insulin resistance. A vasodilating effect of androgel positively influences cardiovascular system and penile vessels. The drug acts fast, is effective and safe. Therefore, it can be recommended for correction of erectile dysfunction in patients with old age androgen deficiency and concurrent cardiovascular diseases.

摘要

老年男性部分雄激素缺乏症(PADAM)表现为性功能障碍,且与许多疾病相关,主要是心血管疾病。30 - 40岁以后,睾酮水平每年下降1 - 2%。睾酮缺乏男性的数量从40 - 60岁年龄段的8%增长至80岁以上年龄段的85%。低睾酮与心血管疾病的危险因素相关,如血脂异常、动脉粥样硬化、低纤维蛋白溶解、胰岛素抵抗和腹部肥胖。雄激素缺乏的纠正可使用药物Androgel,它是一种新的经皮睾酮给药系统。与血管活性药物不同,Androgel影响勃起功能障碍的发病机制,从而减轻心血管风险因素。Androgel为外用药物,比肌肉注射和口服类似物更有效。此外,该药物可改善血脂谱。通过激活脂肪分解,睾酮减少内脏脂肪量,从而降低胰岛素抵抗。Androgel的血管舒张作用对心血管系统和阴茎血管有积极影响。该药物起效快,有效且安全。因此,对于老年雄激素缺乏并发心血管疾病患者的勃起功能障碍纠正,它是可以推荐使用的。

相似文献

1
[Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].雄激素(安特尔)激素疗法对患有勃起功能障碍、老年男性部分雄激素缺乏症和心血管疾病男性的疗效与安全性
Urologiia. 2007 Jan-Feb(1):57, 59-61.
2
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.2型糖尿病、内脏肥胖及部分雄激素缺乏男性的睾酮补充治疗
Aging Male. 2003 Mar;6(1):1-7.
3
Androgen deficiency in the etiology and treatment of erectile dysfunction.雄激素缺乏在勃起功能障碍的病因及治疗中的作用
Urol Clin North Am. 2005 Nov;32(4):457-68, vi-vii. doi: 10.1016/j.ucl.2005.08.002.
4
[Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].[勃起功能障碍和雄激素缺乏患者长期替代激素治疗的安全性]
Urologiia. 2007 Sep-Oct(5):49-51.
5
Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.ESPRIT研究的基本原理、设计与方法:性腺功能减退男性使用1%睾酮凝胶(AndroGel)治疗的能量、性欲与身体比例研究
Aging Male. 2008 Jun;11(2):101-6. doi: 10.1080/13685530802169723.
6
Hormonal supplementation and erectile dysfunction.激素补充与勃起功能障碍
Eur Urol. 2004 May;45(5):535-8. doi: 10.1016/j.eururo.2004.01.005.
7
Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone.对于单独使用西地那非治疗失败的获得性雄激素缺乏综合征男性患者,联合使用安特尔(睾酮凝胶)和西地那非治疗勃起功能障碍。
Urology. 2006 Mar;67(3):571-4. doi: 10.1016/j.urology.2005.09.032.
8
Androgen deficiency in aging and metabolically challenged men.衰老和代谢异常男性的雄激素缺乏。
Urol Clin North Am. 2012 Feb;39(1):63-75. doi: 10.1016/j.ucl.2011.09.007. Epub 2011 Oct 13.
9
Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?定义老年男性的“相对性”雄激素缺乏:应如何测量睾酮,以及雄激素水平与身体、性和情绪健康之间有何关系?
Climacteric. 2002 Mar;5(1):15-25.
10
[Correction of androgen deficiency in elderly patients].[老年患者雄激素缺乏的纠正]
Klin Med (Mosk). 2007;85(9):17-22.

引用本文的文献

1
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.肌肉注射十一酸睾酮治疗男性肥胖相关性继发性性腺功能减退症的代谢表型:治疗前和治疗后。
Endocrine. 2018 Apr;60(1):175-184. doi: 10.1007/s12020-017-1516-x. Epub 2018 Feb 2.